wiki pageCreated: 2026-04-02T07:19:15By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-pde1c-protein
📖 Wiki Page
protein662 wordssynced 2026-04-02
title: PDE1C Protein — Phosphodiesterase 1C category: protein
Phosphodiesterase 1C (PDE1C)
Introduction
Pde1C Protein — Phosphodiesterase 1C is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: PDE1C Protein — Phosphodiesterase 1C category: protein
Phosphodiesterase 1C (PDE1C)
Introduction
Pde1C Protein — Phosphodiesterase 1C is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PDE1C (Phosphodiesterase 1C, encoded by the [PDE1C](/genes/pde1c) gene) is a calcium/calmodulin-dependent phosphodiesterase that hydrolyzes both cAMP and cGMP. It is one of the most abundant phosphodiesterases in the [brain](/brain-regions/brain-overview) and plays crucial roles in [synaptic plasticity](/mechanisms/synaptic-plasticity), memory formation, and neuronal survival.
PDE1C provides a critical link between [calcium signaling](/mechanisms/calcium-signaling-neurodegeneration) and cyclic nucleotide pathways, making it a key regulator of neuronal function and a potential therapeutic target for [neurodegenerative diseases](/diseases/neurodegeneration).
Therapeutic potential: PDE1 inhibitors show promise in AD preclinical studies
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
Dopaminergic signaling: PDE1C regulates cAMP in [dopaminergic neurons](/cell-types/dopaminergic-neurons)[@pdea]
Neuroprotection: PDE1 inhibition protects against MPTP toxicity
Levodopa response: May modulate response to dopaminergic therapy
Huntington's Disease
In [Huntington's disease](/diseases/huntington-disease):
cAMP signaling: PDE1C alterations affect mutant [huntingtin](/proteins/huntingtin) function
Therapeutic targeting: PDE1 inhibitors under investigation
Amyotrophic Lateral Sclerosis (ALS)
In [ALS](/diseases/amyotrophic-lateral-sclerosis):
Motor neuron survival: cAMP dysregulation contributes to [motor neuron degeneration](/cell-types/motor-neurons)
Glial involvement: PDE1C in [astrocytes](/cell-types/astrocytes) affects neuronal support
Therapeutic Targeting
PDE1C is a promising drug target for neurodegenerative diseases:
Inhibitors
Vinpocetine: Traditional PDE1 inhibitor, studied for cognitive enhancement
IC86340: Selective PDE1 inhibitor
KR-36996: Potent PDE1 inhibitor with neuroprotective effects
Clinical Applications
Cognitive enhancement in aging and dementia
Neuroprotection in Parkinson's disease
Adjunct therapy in depression and ADHD
Interactions and Signaling Pathways
PDE1C interacts with:
Calmodulin (activation)
cAMP-dependent protein kinase (PKA)
cGMP-dependent protein kinase (PKG)
CREB transcription factor
Various ion channels
Background
The study of Pde1C Protein — Phosphodiesterase 1C has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.